SIGA Technologies
SIGA
#7361
Rank
โ‚น39.88 B
Marketcap
โ‚น556.99
Share price
-2.21%
Change (1 day)
8.89%
Change (1 year)

Revenue for SIGA Technologies (SIGA)

Revenue in 2025 (TTM): โ‚น14.77 Billion

According to SIGA Technologies's latest financial reports the company's current revenue (TTM ) is โ‚น15.47 Billion. In 2024 the company made a revenue of โ‚น11.90 Billion an increase over the revenue in the year 2023 that were of โ‚น11.64 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SIGA Technologies from 1997 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น14.77 B24.17%
2024 โ‚น11.90 B2.17%
2023 โ‚น11.64 B27.07%
2022 โ‚น9.16 B-7.87%
2021 โ‚น9.94 B8.87%
2020 โ‚น9.13 B379.22%
2019 โ‚น1.90 B-94.28%
2018 โ‚น33.35 B4158.04%
2017 โ‚น0.78 B-23.08%
2016 โ‚น1.01 B87.45%
2015 โ‚น0.54 B173.03%
2014 โ‚น0.19 B-41.64%
2013 โ‚น0.34 B-30.58%
2012 โ‚น0.49 B-27.04%
2011 โ‚น0.67 B-21.82%
2010 โ‚น0.86 B34.36%
2009 โ‚น0.64 B65.31%
2008 โ‚น0.38 B47.47%
2007 โ‚น0.26 B-18.21%
2006 โ‚น0.32 B-15.73%
2005 โ‚น0.38 B378.9%
2004 โ‚น79.65 M139.08%
2003 โ‚น33.31 M
2001 โ‚น55.94 M148.13%
2000 โ‚น22.54 M22.04%
1999 โ‚น18.47 M-13.1%
1998 โ‚น21.26 M-39.89%
1997 โ‚น35.36 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Emergent BioSolutions
EBS
โ‚น67.44 B 335.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น0.23 B-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น92.02 B 494.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น53.88 B 248.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น216.83 B 1,301.29%๐Ÿ‡บ๐Ÿ‡ธ USA